NLRP3 and cardiovascular disorder: From a clinical point of view, NLRP3 inflammasome activation has been suggested as a relevant indicator of cardiovascular disease severity and quantification of its components and end products in circulating cells and plasma/serum arise as novel potential biomarkers.